New role of irisin in hepatocytes: the protective effect of hepatic steatosis in vitro
Abstract
Irisin is a newly identified myokine related to exercise and the browning of white fat. Recently, it was reported that irisin serum levels are associated with intrahepatic triglyceride content, suggesting that it might have an important role in the liver. The aim of this study was to determine the role of irisin in hepatocytes. Specifically, the effect of recombinant irisin on palmitic acid (PA)-induced lipogenesis and its related signal pathways were examined in AML12 cells and mouse primary hepatocytes. In the present study, we observed the presence of irisin inside the cells in response to the treatment of recombinant irisin by flow cytometry and cell imaging technique. Recombinant irisin significantly inhibited the PA-induced increase in lipogenic markers ACC and FAS at the mRNA and protein levels, and prevented the PA-induced lipid accumulation in hepatocytes. Additionally, irisin inhibited the PA-induced increase in the expression, nuclear localization, and transcriptional activities of the master regulators of lipogenesis (LXRα and SREBP-1c). Moreover, irisin attenuated PA-induced oxidative stress, which was confirmed by measuring the expression of inflammatory markers (NFκB, COX-2, p38 MAPK, TNF, IL-6) and superoxide indicator (dihydroethidium). The preventive effects of irisin against lipogenesis and oxidative stress were mediated by the inhibition of protein arginine methyltransferase-3 (PRMT3). These findings suggested that irisin might have a beneficial role in the prevention of hepatic steatosis by altering the expression of lipogenic genes and attenuating oxidative stress in a PRMT3 dependent manner.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The antioxidative and anti-inflammatory effects of irisin in hepatocytes may help decrease hepatic steatosis and favor a healthy hepatokine profile that contributes to decreased fat mass.
“the antioxidative and anti-inflammatory effects of irisin have also been described in hepatocytes, which may help decrease hepatic steatosis [65] and favor a healthy hepatokine profile which also contributes to decreased fat mass [23].”
OCN and irisin may exert direct anti-oxidant and anti-inflammatory effects in the liver.
“OCN [28,215] and irisin [61,65], on the other hand, may also exert direct anti-oxidant and anti-inflammatory effects in the liver.”
Irisin, IL-15, and BAIBA inhibit hepatic lipogenesis.
“while others such as irisin [65], IL-15 [90], and BAIBA [113] have been found to inhibit hepatic lipogenesis (7).”
Recombinant irisin inhibits expression of key regulators of lipogenesis, such as sterol regulatory element-binding protein-1c, and lipogenic enzymes in hepatocytes.
“Studies have demonstrated that recombinant irisin inhibits the expression of key regulators of lipogenesis, such as sterol regulatory element-binding protein-1c, and lipogenic enzymes in hepatocytes (90).”
From Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility (2024) · cites this paper as [90]
Cites
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810 · see citing works
Activation and signaling of the p38 MAP kinase pathway
Zarubin, T., & Han, J. (2005) · Cell Research · doi:10.1038/sj.cr.7290257 · Cited by 1,711 · see citing works
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · see citing works
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,250 · see citing works
Oxidative stress as a crucial factor in liver diseases
Cichoż‐Lach, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i25.8082 · Cited by 1,226 · see citing works
Huh, J. Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B. E., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.002 · Cited by 1,040 · see citing works
Moreno-Navarrete, J. M., Ortega, F., Serrano, M., Guerra, E., Pardo, G., Tinahones, F., Ricart, W., & Fernández-Real, J. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2749 · Cited by 788 · see citing works
Zhang, Y., Li, R., Meng, Y., Li, S., Donelan, W., Zhao, Y., Qi, L., Zhang, M., Wang, X., Cui, T., et al. (2014) · Diabetes · doi:10.2337/db13-1106 · Cited by 733 · see citing works
Kammoun, H. L., Chabanon, H., Hainault, I., Luquet, S., Magnan, C., Koike, T., Ferré, P., & Foufelle, F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37007 · Cited by 732 · see citing works
Ricchi, M., Odoardi, M. R., Carulli, L., Anzivino, C., Ballestri, S., Pinetti, A., Fantoni, L. I., Marra, F., Bertolotti, M., Banni, S., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05733.x · Cited by 652 · see citing works
Lower circulating irisin is associated with type 2 diabetes mellitus
Liu, J., Wong, M. D. S., Toy, W. C., Tan, C., Liu, S., Ng, X. W., Subramaniam, T., Sum, C. F., & Lim, S. C. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.03.002 · Cited by 446 · see citing works
Pessayre, D., & Fromenty, B. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.004 · Cited by 441 · see citing works
Serum irisin levels in new-onset type 2 diabetes
Choi, Y., Kim, M. K., Bae, K.-H., Seo, H.-A., Jeong, J.-Y., Lee, W.-K., Kim, J., Lee, I., & Park, K. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.01.007 · Cited by 422 · see citing works
Contraction-Induced Myokine Production and Release: Is Skeletal Muscle an Endocrine Organ?
Febbraio, M. A., & Pedersen, B. K. (2005) · Exercise and Sport Sciences Reviews · doi:10.1097/00003677-200507000-00003 · Cited by 402 · see citing works
Kurdiova, T., Balaz, M., Vician, M., Maderova, D., Vlcek, M., Valkovic, L., Srbecky, M., Imrich, R., Kyselovicova, O., Belan, V., et al. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.264655 · Cited by 401 · see citing works
SREBP-1c Transcription Factor and Lipid Homeostasis: Clinical Perspective
Ferré, P., & Foufelle, F. (2007) · Hormone Research in Paediatrics · doi:10.1159/000100426 · Cited by 401 · see citing works
Is irisin a human exercise gene?
Timmons, J. A., Baar, K., Davidsen, P. K., & Atherton, P. J. (2012) · Nature · doi:10.1038/nature11364 · Cited by 389 · see citing works
Gao, D., Nong, S., Huang, X., Lu, Y., Zhao, H., Lin, Y., Man, Y., Wang, S., Yang, J., & Li, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128694 · Cited by 325 · see citing works
Recent concepts in non‐alcoholic fatty liver disease
Adams, L. A., & Angulo, P. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01748.x · Cited by 324 · see citing works
Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis.
Wang, X., Zelenski, N. G., Yang, J., Sakai, J., Brown, M. S., & Goldstein, J. L. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00438.x · Cited by 313 · see citing works
Histological assessment of non‐alcoholic fatty liver disease
Hübscher, S. G. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02416.x · Cited by 292 · see citing works
Irisin is inversely associated with intrahepatic triglyceride contents in obese adults
Zhang, H.-J., Zhang, X.-F., Ma, Z.-M., Pan, L.-L., Chen, Z., Han, H.-W., Han, C.-K., Zhuang, X.-J., Lu, Y., Li, X.-J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.030 · Cited by 234 · see citing works
Myokines in insulin resistance and type 2 diabetes
Eckardt, K., Görgens, S. W., Raschke, S., & Eckel, J. (2014) · Diabetologia · doi:10.1007/s00125-014-3224-x · Cited by 221 · see citing works
Pardo, M., Crujeiras, A. B., Amil, M., Agüera, Z., Jiménez‐Múrcia, S., Baños, R., Botella, C., de la Torre, R., Estivill, X., Fagundo, A. B., et al. (2014) · International Journal of Endocrinology · doi:10.1155/2014/857270 · Cited by 216 · see citing works
Daskalopoulou, S. S., Cooke, A. B., Sandoval, Y.-H. G., Mutter, A. F., Filippaios, A., Mesfum, E. T., & Mantzoros, C. S. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0204 · Cited by 216 · see citing works
Irisin in patients with nonalcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., Anastasilakis, A. D., Geladari, E. V., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2013.09.013 · Cited by 215 · see citing works
Raschke, S., Eckardt, K., Bjørklund Holven, K., Jensen, J., & Eckel, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062008 · Cited by 199 · see citing works
Non-alcoholic steatohepatitis: From cell biology to clinical practice
Cortez‐Pinto, H., de Moura, M. C., & Day, C. P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.002 · Cited by 193 · see citing works
Norheim, F., Raastad, T., Thiede, B., Rustan, A. C., Drevon, C. A., & Haugen, F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00326.2011 · Cited by 180 · see citing works
Secretome profiling of primary human skeletal muscle cells
Hartwig, S., Raschke, S., Knebel, B., Scheler, M., Irmler, M., Paßlack, W., Müller, S., Hanisch, F., Franz, T., Li, X., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.08.004 · Cited by 168 · see citing works
Goebeler, M., Gillitzer, R., Kilian, K., Utzel, K., Bröcker, E., Rapp, U. R., & Ludwig, S. (2001) · Blood · doi:10.1182/blood.v97.1.46 · Cited by 160 · see citing works
Ojima, A., Ishibashi, Y., Matsui, T., Maeda, S., Nishino, Y., Takeuchi, M., Fukami, K., & Yamagishi, S.-I. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.09.016 · Cited by 156 · see citing works
Irisin in response to acute and chronic whole-body vibration exercise in humans
Huh, J. Y., Mougios, V., Skraparlis, A. N., Kabasakalis, A., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.001 · Cited by 112 · see citing works
Mechanisms of non-alcoholic steatohepatitis
McClain, C. J., Mokshagundam, S. P., Barve, S. S., Song, Z., Hill, D. B., Chen, T., & Deaciuc, I. V. (2004) · Alcohol · doi:10.1016/j.alcohol.2004.07.007 · Cited by 101 · see citing works
Park, M.-J., Kim, D., Lim, S.-K., Choi, J., Kim, J.-C., Yoon, K. C., Lee, J.-B., Lee, J.-H., Han, H. J., Choi, I., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.032 · Cited by 99 · see citing works
Onozato, M. L., Tojo, A., LEIPER, J. M., Fujita, T., Palm, F., & Wilcox, C. S. (2007) · Diabetes · doi:10.2337/db06-1772 · Cited by 98 · see citing works
Xiang, L., Xiang, G., Yue, L., Zhang, J., & Zhao, L. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.04.036 · Cited by 95 · see citing works
Role of PRMTs in cancer: Could minor isoforms be leaving a mark?
Baldwin, R. M. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i2.115 · Cited by 90 · see citing works
Park, M.-J., Kim, D., Lim, S.-K., Choi, J., Han, H. J., Yoon, K. C., & Park, S.-H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.530139 · Cited by 90 · see citing works
Kim, D., Lim, S.-K., Park, M.-J., Choi, J., Kim, J., Han, H. J., Yoon, K. C., Kim, K., Lim, J. H., & Park, S. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.008 · Cited by 76 · see citing works
PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy
Chen, Y., Xu, X., Sheng, M., Zhang, X., Gu, Q., & Zheng, Z. J. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.09.004 · Cited by 72 · see citing works
Choi, E. S., Kim, M. K., Song, M. K., Kim, J., Kim, E. S., Chung, W. J., Park, K. S., Cho, K. B., Hwang, J. S., & Jang, B. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110680 · Cited by 58 · see citing works
Besse‐Patin, A., & Estall, J. L. (2014) · International Journal of Cell Biology · doi:10.1155/2014/519153 · Cited by 58 · see citing works
PRMT3 Regulates Hepatic Lipogenesis Through Direct Interaction With LXRα
Kim, D., Park, M.-J., Lim, S.-K., Park, J., Yoon, K. C., Han, H. J., Gustafsson, J.-Α., Lim, J. H., & Park, S.-H. (2014) · Diabetes · doi:10.2337/db13-1394 · Cited by 49 · see citing works
Ouadda, A. B. D., Levy, E. H., Ziv, E., Lalonde, G., Sané, A. T., Delvin, E., & Elchebly, M. (2008) · Bioscience Reports · doi:10.1042/bsr20080141 · Cited by 40 · see citing works
Tormos, A., Arduini, A., Taléns-Visconti, R., Barrantes, I. D. B., Nebreda, A., & Sastre, J. (2013) · Hepatology · doi:10.1002/hep.26174 · Cited by 39 · see citing works
Impaired PRMT1 activity in the liver and pancreas of type 2 diabetic Goto–Kakizaki rats
Iwasaki, H. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.05.007 · Cited by 39 · see citing works
Evaluation of an in vitro toxicogenetic mouse model for hepatotoxicity
Martinez, S. M., Bradford, B. U., Soldatow, V. Y., Kosyk, O., Sandot, A., Witek, R. P., Kaiser, R. A., Stewart, T. W., Amaral, K. B., Freeman, K., et al. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.09.012 · Cited by 26 · see citing works
One session of exercise or endurance training does not influence serum levels of irisin in rats.
Czarkowska‐Pączek, B., Zendzian-Piotrowska, M., Gala, K., Sobol, M., & Pączek, L. (2014) · PubMed · Cited by 26 · see citing works
Cheng, J.-W., Cheng, S., Cai, J.-P., Li, Y., & Wei, R.-L. (2012) · Ophthalmic Research · doi:10.1159/000327144 · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Physiology and role of irisin in glucose homeostasis
Perakakis, N., Triantafyllou, G. A., Fernández-Real, J. M., Huh, J. Y., Park, K. H., Seufert, J., & Mantzoros, C. S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.221 · Cited by 621 · see citing works
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review
Hashida, R., Kawaguchi, T., Bekki, M., Omoto, M., Matsuse, H., Nago, T., Takano, Y., Ueno, T., Koga, H., George, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.023 · Cited by 509 · see citing works
Gonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278 · see citing works
“For instance, BAIBA [104] and FGF21 [160] have been shown to increase hepatic β-oxidation (6), while others such as irisin [65], IL-15 [90], and BAIBA [113] have been found to inhibit hepatic lipogenesis (7).”
BackgroundInfluentialPolyzos, S. A., Anastasilakis, A. D., Efstathiadou, Z. A., Makras, P., Perakakis, N., Kountouras, J., & Mantzoros, C. S. (2018) · Endocrine · doi:10.1007/s12020-017-1476-1 · Cited by 262 · see citing works
Irisin protects mitochondria function during pulmonary ischemia/reperfusion injury
Chen, K., Xu, Z., Liu, Y., Wang, Z., Li, Y., Xu, X., Chen, C., Xia, T., Liao, Q., Yao, Y., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aao6298 · Cited by 208 · see citing works
Mazur-Bialy, A. I., Pocheć, E., & Zarawski, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040701 · Cited by 203 · see citing works
Askari, H., Rajani, S. F., Poorebrahim, M., Haghi‐Aminjan, H., Raeis-Abdollahi, E., & Abdollahi, M. R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.012 · Cited by 188 · see citing works
Myokines mediate the cross talk between skeletal muscle and other organs
Chen, W., Wang, L., You, W., & Shan, T. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30033 · Cited by 162 · see citing works
Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling
Tang, H. W., Yu, R., Liu, S., Huwatibieke, B., Li, Z., & Zhang, W. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.041 · Cited by 151 · see citing works
Wei, S., Bi, J., Yang, L., Zhang, J., Wan, Y., Chen, X., Wang, Y., Wu, Z., Lv, Y., & Wu, R. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.173 · Cited by 145 · see citing works
Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury
Wang, H., Zhao, Y., Zhang, S.-Y., Dubielecka, P., Du, J., Yano, N., Chin, Y., Zhuang, S., Qin, G., & Zhao, T. C. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25857 · Cited by 136 · see citing works
Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic β cells
Liu, S.-W., Du, F., Li, X., Wang, M.-M., Duan, R., Zhang, J.-X., Wu, Y., & Zhang, Q. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175498 · Cited by 138 · see citing works
Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity
INSERM, U., & Fromenty, B. (2017) · Journal of Clinical and Translational Research · doi:10.18053/jctres.03.2017s1.006 · Cited by 124 · see citing works
Natalicchio, A., Marrano, N., Biondi, G., Spagnuolo, R., Labarbuta, R., Porreca, I., Cignarelli, A., Bugliani, M., Marchetti, P., Perrini, S., et al. (2017) · Diabetes · doi:10.2337/db17-0002 · Cited by 121 · see citing works
Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2
Zhu, W., Sahar, N.-E., Javaid, H. M. A., Pak, E. S., Liang, G., Wang, Y., Ha, H., & Huh, J. Y. (2021) · Cells · doi:10.3390/cells10123306 · Cited by 116 · see citing works
An update on the role of irisin in the regulation of endocrine and metabolic functions
Mahgoub, M., D’Souza, C. M., Darmaki, R. S. A., Baniyas, M. M. Y. H., & Adeghate, E. A. (2018) · Peptides · doi:10.1016/j.peptides.2018.03.018 · Cited by 109 · see citing works
Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
Kuchay, M. S., Martínez‐Montoro, J. I., Choudhary, N. S., Fernández‐García, J. C., & Ramos‐Molina, B. (2021) · Biomedicines · doi:10.3390/biomedicines9101346 · Cited by 103 · see citing works
Ding, Q., Cao, F., Lai, S., Zhuge, H., Chang, K., Valencak, T. G., Liu, J., Li, S., & Ren, D. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111259 · Cited by 101 · see citing works
Jin, Y., Sumsuzzman, D. M., Choi, J., Kang, H., Lee, S., & Hong, Y. (2018) · Molecules · doi:10.3390/molecules23123229 · Cited by 96 · see citing works
Babu, A. F., Csader, S., Lok, J., Gómez-Gallego, C., Hanhineva, K., El-Nezami, H. S., & Schwab, U. (2021) · Nutrients · doi:10.3390/nu13093135 · Cited by 96 · see citing works
Irisin Is Regulated by CAR in Liver and Is a Mediator of Hepatic Glucose and Lipid Metabolism.
Mo, L., Shen, J., Liu, Q.-H., Zhang, Y., Kuang, J.-Y., Pu, S.-Y., Cheng, S., Zou, M., Jiang, W., Jiang, C.-T., et al. (2016) · Molecular Endocrinology · doi:10.1210/me.2015-1292 · Cited by 87 · see citing works
So, W. Y., & Leung, P. S. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.022 · Cited by 83 · see citing works
Irisin, a unique non-inflammatory myokine in stimulating skeletal muscle metabolism
Vaughan, R. A., Gannon, N. P., Mermier, C. M., & Conn, C. A. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0433-9 · Cited by 77 · see citing works
Mejía-Guzmán, J. E., Belmont-Hernández, R. A., Chávez-Tapia, N. C., Uribe, M., & Nuño‐Lámbarri, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072959 · Cited by 72 · see citing works
Zheng, S., Chen, N., Kang, X.-J., Hu, Y., & Shi, S. (2021) · Endocrine · doi:10.1007/s12020-021-02875-y · Cited by 69 · see citing works
Mambrini, S. P., Grillo, A., Colosimo, S., Zarpellon, F., Pozzi, G., Furlan, D., Amodeo, G., & Bertoli, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1426551 · Cited by 70 · see citing works
Increased FNDC5/Irisin expression in human hepatocellular carcinoma
Gaggini, M., Cabiati, M., Turco, S. D., Navarra, T., SIMONE, P. D., Filipponi, F., Ry, S. D., Gastaldelli, A., & Basta, G. (2016) · Peptides · doi:10.1016/j.peptides.2016.12.014 · Cited by 68 · see citing works
A Review on the Role of Irisin in Insulin Resistance and Type 2 Diabetes Mellitus.
Gizaw, M., Anandakumar, P., & Tolessa, D. (2017) · Europe PMC (PubMed Central) · doi:10.3831/kpi.2017.20.029 · Cited by 68 · see citing works
RetractedZhang, D., Xie, T., & Leung, P. S. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495395 · Cited by 65 · see citing works
Kang, S., Moon, M. K., Kim, W. K., & Koo, B. K. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12598 · Cited by 64 · see citing works
Irisin acts as a regulator of macrophages host defense
Mazur-Biały, A. I. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.03.011 · Cited by 64 · see citing works
Xin, C., Zhang, Z., Gao, G., Ding, L., Yang, C., Wang, C.-Z., Liu, Y.-J., Guo, Y.-F., Yang, X.-Q., Zhang, L.-J., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565160 · Cited by 52 · see citing works
Kubo, H., Asai, K., Kojima, K., Sugitani, A., Kyomoto, Y., Okamoto, A., Yamada, K., Ijiri, N., Watanabe, T., Hirata, K., et al. (2019) · International Journal of COPD · doi:10.2147/copd.s226623 · Cited by 60 · see citing works
Irisin Ameliorates Hypoxia/Reoxygenation-Induced Injury through Modulation of Histone Deacetylase 4
Zhao, Y., Wang, H., Zhang, S.-Y., Du, J., Zhuang, S., & Zhao, T. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166182 · Cited by 58 · see citing works
The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity
Li, H., Wang, F., Mu, Y., Sun, J., Zhao, Y. C., & Tang, D. (2021) · International Journal of Endocrinology · doi:10.1155/2021/6572342 · Cited by 59 · see citing works
Daneshi‐Maskooni, M., Keshavarz, S. A., Qorbani, M., Mansouri, S., Alavian, S. M., Badri-Fariman, M., Jazayeri-Tehrani, S. A., & Sotoudeh, G. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2465-0 · Cited by 57 · see citing works
Pérez-Sotelo, D., Roca-Rivada, A., de la Torre, I. B., Baltar, J., Castro, A. I., Domínguez, E., Collado, M., Casanueva, F. F., & Pardo, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-16602-z · Cited by 59 · see citing works
Zhao, Y., Wang, J., Yano, N., Zhang, L. X., Wang, H., Zhang, S.-Y., Qin, G., Dubielecka, P., Zhuang, S., Liu, P., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27037 · Cited by 57 · see citing works
Cosio, P. L., Crespo-Posadas, M., Velarde-Sotres, Á., & Pelaez, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052476 · Cited by 56 · see citing works
Marrano, N., Biondi, G., Borrelli, A., Cignarelli, A., Perrini, S., Laviola, L., Giorgino, F., & Natalicchio, A. (2021) · Biomolecules · doi:10.3390/biom11020286 · Cited by 56 · see citing works
An update on the validity of irisin assays and the link between irisin and hepatic metabolism
Pοlyzos, S. A., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2015.06.005 · Cited by 56 · see citing works
Vázquez-Jiménez, J. G., Chávez‐Reyes, J., Romero‐García, T., Zarain‐Herzberg, Á., Valdés, J., Galindo-Rosales, J. M., Rueda, A., Guerrero-Hernández, A., & Olivares-Reyes, J. A. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.10.001 · Cited by 56 · see citing works
Daneshi‐Maskooni, M., Keshavarz, S. A., Qorbani, M., Mansouri, S., Alavian, S. M., Badri-Fariman, M., Jazayeri-Tehrani, S. A., & Sotoudeh, G. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0297-4 · Cited by 56 · see citing works
Takahashi, H., Kotani, K., Tanaka, K., Egucih, Y., & Anzai, K. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00588 · Cited by 55 · see citing works
Elizondo‐Montemayor, L., González-Gil, A. M., Tamez‐Rivera, O., Toledo‐Salinas, C., Peschard-Franco, M., Rodríguez-Gutiérrez, N. A., Silva‐Platas, C., & García‐Rivas, G. (2019) · Mediators of Inflammation · doi:10.1155/2019/6737318 · Cited by 55 · see citing works
Petta, S., Valenti, L. V. C., Svegliati‐Baroni, G., Ruscica, M., Pipitone, R. M., Dongiovanni, P., Rychlicki, C., Ferri, N., Cammà, C., Fracanzani, A. L., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00056 · Cited by 50 · see citing works
Dihingia, A., Bordoloi, J., Dutta, P., Kalita, J., & Manna, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-27607-7 · Cited by 50 · see citing works
The bone anabolic effects of irisin are through preferential stimulation of aerobic glycolysis
Zhang, D., Bae, C., Lee, J., Lee, J., Jin, Z., Kang, M., Cho, Y.-S., Kim, J.-H., Lee, W., & Lim, S.-K. (2018) · Bone · doi:10.1016/j.bone.2018.05.013 · Cited by 46 · see citing works
(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46 · see citing works
Bordoloi, J., Ozah, D., Bora, T., Kalita, J., & Manna, P. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.05.006 · Cited by 45 · see citing works
Lower levels of irisin in patients with type 2 diabetes mellitus: A meta-analysis
Song, R., Zhao, X., Zhang, D., Wang, R., & Feng, Y. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108788 · Cited by 45 · see citing works
Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus
Ruszała, M., Niebrzydowska-Tatus, M., Pilszyk, A., Kimber-Trojnar, Ż., Trojnar, M. P., & Leszczyńska‐Gorzelak, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111578 · Cited by 46 · see citing works
Nascè, A., Gariani, K., Jornayvaz, F. R., & Szántó, I. (2022) · Antioxidants · doi:10.3390/antiox11061131 · Cited by 47 · see citing works
The Physiological Role of Irisin in the Regulation of Muscle Glucose Homeostasis
Yano, N., Zhao, Y., & Zhao, T. C. (2021) · Endocrines · doi:10.3390/endocrines2030025 · Cited by 46 · see citing works
Kanıskan, H. Ü., Eram, M. S., Zhao, K., Szewczyk, M. M., Yang, X., Schmidt, K. T., Luo, X. M., Xiao, S., Dai, M., He, F., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01674 · Cited by 42 · see citing works
Matz‐Soja, M., Berg, T., & Kietzmann, T. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.08.007 · Cited by 49 · see citing works
Excessive irisin increases oxidative stress and apoptosis in murine heart
Ho, M.-Y., Wen, M., Yeh, J., Hsieh, C., Chen, C., Hsieh, M., Tsai, M., Yang, C., Wu, V. C., Hung, K., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.005 · Cited by 41 · see citing works
Kheiripour, N., Karimi, J., Khodadadi, I., Tavilani, H., Goodarzi, M. T., & Hashemnia, M. (2019) · Europe PMC (PubMed Central) · doi:10.30476/ijms.2019.44511 · Cited by 40 · see citing works
Delgado, A. S. H., Roffe-Vazquez, D. N., González-Gil, A. M., Villarreal-Calderón, J. R., Tamez‐Rivera, O., Rodríguez-Gutiérrez, N. A., Castillo, E. C., Silva‐Platas, C., García‐Rivas, G., & Elizondo‐Montemayor, L. (2020) · Journal of Diabetes Research · doi:10.1155/2020/1949415 · Cited by 40 · see citing works
Irisin at the crossroads of inter-organ communications: Challenge and implications
Zhao, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.989135 · Cited by 40 · see citing works
Hsu, S., & Hung, W. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.216008 · Cited by 36 · see citing works
Belviranlı, M., & Okudan, N. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0053 · Cited by 35 · see citing works
New insight of obesity-associated NAFLD: Dysregulated “crosstalk” between multi-organ and the liver?
Wang, Y., Wu, L.-L., Qi, X.-Y., Wang, Y.-Y., Liao, Z., Liu, J., & Xiao, X. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.12.013 · Cited by 35 · see citing works
Pan, J.-A., Zhang, H., Yu, Q., Zhang, J.-F., Wang, C.-Q., Gu, J., & Chen, K. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.02.020 · Cited by 34 · see citing works
Daneshi‐Maskooni, M., Keshavarz, S. A., Mansouri, S., Qorbani, M., Alavian, S. M., Badri-Fariman, M., Jazayeri-Tehrani, S. A., & Sotoudeh, G. (2017) · Trials · doi:10.1186/s13063-017-1979-3 · Cited by 33 · see citing works
Mika, A., Sikorska-Wiśniewska, M., Małgorzewicz, S., Stepnowski, P., Dębska-Ślizień, A. M., Śledziński, T., & Chmielewski, M. S. (2018) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.4376 · Cited by 33 · see citing works
Irisin: circulating levels in serum and its relation to gonadal axis
Luo, Y., Qiao, X., Xu, L.-Z., & Huang, G.-N. (2022) · Endocrine · doi:10.1007/s12020-022-02981-5 · Cited by 30 · see citing works
PRMT3 interacts with ALDH1A1 and regulates gene-expression by inhibiting retinoic acid signaling
Verma, M., Khan, M. I. K., Kadumuri, R. V., Chakrapani, B., Awasthi, S., Mahesh, A., Govindaraju, G., Chavali, P. L., Rajavelu, A., Chavali, S., et al. (2021) · Communications Biology · doi:10.1038/s42003-020-01644-3 · Cited by 29 · see citing works
Yue, R., Lv, M., Lan, M., Zheng, Z., Tan, X., Zhao, X., Zhang, Y., Pu, J., Xu, L., & Hu, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-11343-0 · Cited by 29 · see citing works
TLR4/AP-1-Targeted Anti-Inflammatory Intervention Attenuates Insulin Sensitivity and Liver Steatosis
Hu, X., Zhou, J., Song, S., Kong, W., Shi, Y., Chen, L., & Zeng, T. (2020) · Mediators of Inflammation · doi:10.1155/2020/2960517 · Cited by 28 · see citing works
Paoli, A. (2025) · Nutrients · doi:10.3390/nu17040663 · Cited by 26 · see citing works
The Potential of Irisin as a Therapeutic for Diabetes
Leung, P. S. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0035 · Cited by 25 · see citing works
Antioxidant Effects of Irisin in Liver Diseases: Mechanistic Insights
Zhao, J., Qiao, L.-L., Dong, J., & Wu, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3563518 · Cited by 24 · see citing works
The Role of Irisin throughout Women’s Life Span
Barbagallo, F., Cannarella, R., Garofalo, V., Marino, M., Vignera, S. L., Condorelli, R. A., Tiranini, L., Nappi, R. E., & Calogero, A. E. (2023) · Biomedicines · doi:10.3390/biomedicines11123260 · Cited by 24 · see citing works
Relationship between Irisin Concentration and Serum Cytokines in Mother and Newborn
Hernández‐Trejo, M., García‐Rivas, G., Torres‐Quintanilla, A., & Laresgoiti‐Servitje, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165229 · Cited by 24 · see citing works
Does iris(in) bring bad news or good news?
Buscemi, S., Corleo, D., Buscemi, C., & Giordano, C. S. D. S. (2017) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-017-0431-8 · Cited by 24 · see citing works
Nahon, J. E., Groeneveldt, C., Geerling, J. J., Eck, M. V., & Hoekstra, M. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14361 · Cited by 24 · see citing works
Irisin Regulates the Functions of Hepatic Stellate Cells
Dong, H. N., Park, S. Y., Le, C. T., Choi, D.-H., & Cho, E.-H. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.658 · Cited by 23 · see citing works
Adipokines regulate the development and progression of MASLD through organellar oxidative stress
Zhao, K., Zhang, H., Ding, W., Yu, X., Hou, Y., Liu, X., Li, X., & Wang, X. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000639 · Cited by 25 · see citing works
Wang, J., Zhao, Y., Zhang, L. X., Dubielecka, P., Zhuang, S., Qin, G., Chin, Y., Zhang, S.-Y., & Zhao, T. C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00769 · Cited by 19 · see citing works
Bae, J. Y. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17228307 · Cited by 22 · see citing works
Therapeutic potential of exercise-hormone irisin in Alzheimer’s disease
Kim, E., Tanzi, R. E., & Choi, S. H. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00098 · Cited by 22 · see citing works
The Role of Irisin, Insulin and Leptin in Maternal and Fetal Interaction
Ökdemir, D., Hatipoğlu, N., Kurtoğlu, S., Şıraz, Ü. G., Akar, H. H., Muhtaroğlu, S., & Kütük, M. S. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.0096 · Cited by 22 · see citing works
Investigating fibrosis and inflammation in an ex vivo NASH murine model
Gore, E., Bigaeva, E., Oldenburger, A., Jansen, Y. J. M., Schuppan, D., Boersema, M., Rippmann, J. F., Broermann, A., & Olinga, P. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00209.2019 · Cited by 22 · see citing works
Mohammadi, M. R., Abbasalipourkabir, R., & Ziamajidi, N. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1789881 · Cited by 23 · see citing works
Serum Irisin Levels and Clinical Implication in Elderly Patients With Type 2 Diabetes Mellitus
Xuan, X., Lin, J., Zhang, Y., Zhou, L., Xu, L., Jia, J., Zhao, B., Lin, Z., Zhu, Q. N., Li, L., et al. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4261 · Cited by 21 · see citing works
Souza-Tavares, H., Santana-Oliveira, D. A., Vasques‐Monteiro, I. M. L., Silva-Veiga, F. M., Mandarim‐de‐Lacerda, C. A., & Souza‐Mello, V. (2024) · Nutrition Research · doi:10.1016/j.nutres.2024.04.002 · Cited by 20 · see citing works
Comparison of irisin hormone expression between thyroid cancer tissues and oncocytic variant cells
Uğur, K., Aydın, S., Kuloğlu, T., Artaş, G., Koçdor, M. A., Şahin, İ., Yardım, M., & Özercan, İ. H. (2019) · Cancer Management and Research · doi:10.2147/cmar.s201979 · Cited by 19 · see citing works
Irisin in degenerative musculoskeletal diseases: Functions in system and potential in therapy
Wang, Y.-T., Zheng, S., Jiang, S., Luo, Y., Wu, Y., Naranmandakh, S., Li, Y., Liu, S.-G., & Xiao, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107480 · Cited by 21 · see citing works
Molecular Basis of Irisin Regulating the Effects of Exercise on Insulin Resistance
Lin, J., Liu, X., Zhou, Y., Zhu, B., Wang, Y., Cui, W., Peng, Y., Wang, B., Chen, Z., & Zhao, R. (2022) · Applied Sciences · doi:10.3390/app12125837 · Cited by 18 · see citing works
Cui, Y., Chang, R., Zhang, T., Zhou, X., Wang, Q., Gao, H., Hou, L., Loor, J. J., & Xu, C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01190 · Cited by 18 · see citing works
Vasyukova, O. V., Kasyanova, Y. V., Okorokov, P. L., & Bezlepkina, O. B. (2021) · Problems of Endocrinology · doi:10.14341/probl12779 · Cited by 18 · see citing works
Ciałowicz, M., Woźniewski, M., Murawska‐Ciałowicz, E., & Dzięgiel, P. (2025) · Cells · doi:10.3390/cells14161228 · Cited by 16 · see citing works
The role of Irisin in multiorgan protection
Ma, J., & Chen, K. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06067-1 · Cited by 17 · see citing works
Ji, J., Jiao, W., Cheng, Y., Yan, H., Su, F., & Chi, L.-L. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487728 · Cited by 16 · see citing works
Abdulghani, A., Poghosyan, M., Mehren, A., Philipsen, A., & Anderzhanova, E. A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.997054 · Cited by 15 · see citing works
Irisin Protects Against Hind Limb Ischemia Reperfusion Injury
Küçük, A., Polat, Y., Kılıçarslan, A., Süngü, N., Kartal, H., Dursun, A. D., & Arslan, M. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s279318 · Cited by 15 · see citing works
Lingling, C., Qiao, T., Xu, F., Li, Z., Chen, T., Su, H., Chen, G., Zhang, L., Xu, D., & Zhang, X. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154924 · Cited by 15 · see citing works
Swargiary, D., Kashyap, B., Sarma, P., Ahmed, S. A., Gurumayum, S., Barge, S., Basumatary, D., & Borah, J. C. (2024) · Fitoterapia · doi:10.1016/j.fitote.2023.105803 · Cited by 14 · see citing works
Effect of Heat Stimulation on Circulating Irisin in Humans
Park, T.-H., Lee, H.-J., & Lee, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.675377 · Cited by 14 · see citing works
- Authors
- Park, M.-J., Kim, D.-I., Choi, J.-H., Heo, Y.-R., & Park, S.-H.
- Affiliations
- Chonnam National University (KR)
- Corresponding author
- Heo, Young-Ran
- Park, Soo-Hyun
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 27
- Issue
- 9
- Pages
- 1831-1839
- ISSN
- 0898-6568 (ISSN-L)
- OpenAlex
- W2043905763
- Cited by
- 168
- References
- 50
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 18 · 2023: 13 · 2022: 15 · 2021: 23 · 2020: 17 · 2019: 13 · 2018: 18 · 2017: 17 · 2016: 7 · 2015: 5
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cellular Signalling (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- irisin, hepatic steatosis, hepatocytes, palmitic acid, lipogenesis, oxidative stress, PRMT3, liver X receptor alpha, SREBP-1c, myokines, lipid accumulation, AML12 cells
- MeSH terms
- Liver X Receptors, Animals, Cell Line, Fatty Liver, Fibronectins, Cytokines, Oxidative Stress, Palmitic Acid, Hepatocytes, Mice, Sterol Regulatory Element Binding Protein 1, Orphan Nuclear Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review